{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T18:11:54Z","timestamp":1791137514213,"version":"4.1.0"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2011,12,13]],"date-time":"2011-12-13T00:00:00Z","timestamp":1323734400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Graefes Arch Clin Exp Ophthalmol"],"published-print":{"date-parts":[[2012,1]]},"DOI":"10.1007\/s00417-011-1889-0","type":"journal-article","created":{"date-parts":[[2011,12,12]],"date-time":"2011-12-12T09:30:31Z","timestamp":1323682231000},"page":"3-13","source":"Crossref","is-referenced-by-count":24,"title":["Recent trends in the management of maculopathy secondary to pathological myopia"],"prefix":"10.1007","volume":"250","author":[{"given":"D.","family":"Mitry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Zambarakji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,12,13]]},"reference":[{"key":"1889_CR1","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1136\/bjo.2005.087999","volume":"90","author":"SM Saw","year":"2006","unstructured":"Saw SM (2006) How blinding is pathological myopia? Br J Ophthalmol 90:525\u2013526","journal-title":"Br J Ophthalmol"},{"key":"1889_CR2","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1136\/bjo.2006.096776","volume":"91","author":"I Yamamoto","year":"2007","unstructured":"Yamamoto I, Rogers AH, Reichel E, Yates PA, Duker JS (2007) Intravitreal bevacizumab (Avastin) as treatment for subfoveal choroidal neovascularisation secondary to pathological myopia. Br J Ophthalmol 91:157\u2013160","journal-title":"Br J Ophthalmol"},{"key":"1889_CR3","first-page":"645","volume":"134","author":"Y Tano","year":"2002","unstructured":"Tano Y (2002) Pathologic myopia: where are we now? Am. J Ophthalmol 134:645\u2013660","journal-title":"J Ophthalmol"},{"key":"1889_CR4","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1016\/S0161-6420(01)01007-7","volume":"109","author":"T Yoshida","year":"2002","unstructured":"Yoshida T, Ohno-Matsui K, Ohtake Y, Takashima T, Futagami S, Baba T, Yasuzumi K, Tokoro T, Mochizuki M (2002) Long-term visual prognosis of choroidal neovascularization in high myopia: a comparison between age groups. Ophthalmology 109:712\u2013719","journal-title":"Ophthalmology"},{"key":"1889_CR5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0161-6420(01)00544-9","volume":"108","author":"AN Other","year":"2001","unstructured":"Verteporfin in Photodynamic Therapy Study Group (2001) Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin. 1-year results of a randomized clinical trial--VIP report no. 1. Ophthalmology 108:841\u2013852","journal-title":"Ophthalmology"},{"key":"1889_CR6","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0161-6420(03)00461-5","volume":"110","author":"T Yoshida","year":"2003","unstructured":"Yoshida T, Ohno-Matsui K, Yasuzumi K, Kojima A, Shimada N, Futagami S, Tokoro T, Mochizuki M (2003) Myopic choroidal neovascularization: a 10-year follow-up. Ophthalmology 110:1297\u20131305","journal-title":"Ophthalmology"},{"key":"1889_CR7","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00006982-199212020-00009","volume":"12","author":"HE Grossniklaus","year":"1992","unstructured":"Grossniklaus HE, Green WR (1992) Pathologic findings in pathologic myopia. Retina 12:127\u2013133","journal-title":"Retina"},{"key":"1889_CR8","doi-asserted-by":"crossref","first-page":"50","DOI":"10.3109\/09286580903450346","volume":"17","author":"M Yamada","year":"2010","unstructured":"Yamada M, Hiratsuka Y, Roberts CB, Pezzullo ML, Yates K, Takano S, Miyake K, Taylor HR (2010) Prevalence of visual impairment in the adult Japanese population by cause and severity and future projections. Ophthalmic Epidemiol 17:50\u201357","journal-title":"Ophthalmic Epidemiol"},{"key":"1889_CR9","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ophtha.2003.05.011","volume":"111","author":"WM Hsu","year":"2004","unstructured":"Hsu WM, Cheng CY, Liu JH, Tsai SY, Chou P (2004) Prevalence and causes of visual impairment in an elderly Chinese population in Taiwan: the Shihpai Eye Study. Ophthalmology 111:62\u201369","journal-title":"Ophthalmology"},{"key":"1889_CR10","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1001\/archopht.122.4.495","volume":"122","author":"JH Kempen","year":"2004","unstructured":"Kempen JH, Mitchell P, Lee KE, Tielsch JM, Broman AT, Taylor HR, Ikram MK, Congdon NG, O\u2019Colmain BJ (2004) The prevalence of refractive errors among adults in the United States, Western Europe, and Australia. Arch Ophthalmol 122:495\u2013505","journal-title":"Arch Ophthalmol"},{"key":"1889_CR11","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1097\/ICU.0b013e32832f8040","volume":"20","author":"DM Hornbeak","year":"2009","unstructured":"Hornbeak DM, Young TL (2009) Myopia genetics: a review of current research and emerging trends. Curr Opin Ophthalmol 20:356\u2013362","journal-title":"Curr Opin Ophthalmol"},{"key":"1889_CR12","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2741\/3625","volume":"15","author":"FK Jacobi","year":"2010","unstructured":"Jacobi FK, Pusch CM (2010) A decade in search of myopia genes. Front Biosci 15:359\u2013372","journal-title":"Front Biosci"},{"issue":"1595\u2013611","key":"1889_CR13","first-page":"1611","volume":"117","author":"K Hayashi","year":"2010","unstructured":"Hayashi K, Ohno-Matsui K, Shimada N, Moriyama M, Kojima A, Hayashi W, Yasuzumi K, Nagaoka N, Saka N, Yoshida T, Tokoro T, Mochizuki M (2010) Long-term pattern of progression of myopic maculopathy: a natural history study. Ophthalmology 117(1595\u2013611):1611","journal-title":"Ophthalmology"},{"key":"1889_CR14","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1136\/bjo.2005.081992","volume":"90","author":"YF Shih","year":"2006","unstructured":"Shih YF, Ho TC, Hsiao CK, Lin LL (2006) Visual outcomes for high myopic patients with or without myopic maculopathy: a 10\u00a0year follow up study. Br J Ophthalmol 90:546\u2013550","journal-title":"Br J Ophthalmol"},{"key":"1889_CR15","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/S0161-6420(84)34116-1","volume":"91","author":"MP Avila","year":"1984","unstructured":"Avila MP, Weiter JJ, Jalkh AE, Trempe CL, Pruett RC, Schepens CL (1984) Natural history of choroidal neovascularization in degenerative myopia. Ophthalmology 91:1573\u20131581","journal-title":"Ophthalmology"},{"key":"1889_CR16","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/S0161-6420(01)01024-7","volume":"109","author":"J Vongphanit","year":"2002","unstructured":"Vongphanit J, Mitchell P, Wang JJ (2002) Prevalence and progression of myopic retinopathy in an older population. Ophthalmology 109:704\u2013711","journal-title":"Ophthalmology"},{"key":"1889_CR17","first-page":"1143","volume-title":"Retina","author":"G Soubrane","year":"1984","unstructured":"Soubrane G, Coscas GJ (1994) Choroidal neovascular membranes in degenerative myopia. In: Ryan SJ (ed) Retina. Mosby, St Louis, pp 1143\u20131157"},{"key":"1889_CR18","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0161-6420(96)30515-0","volume":"103","author":"SY Cohen","year":"1996","unstructured":"Cohen SY, Laroche A, Leguen Y, Soubrane G, Coscas GJ (1996) Etiology of choroidal neovascularization in young patients. Ophthalmology 103:1241\u20131244","journal-title":"Ophthalmology"},{"key":"1889_CR19","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00417-004-0960-5","volume":"243","author":"K Hayashi","year":"2005","unstructured":"Hayashi K, Ohno-Matsui K, Yoshida T, Kobayashi K, Kojima A, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2005) Characteristics of patients with a favorable natural course of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 243:13\u201319","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR20","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1007\/s00417-003-0803-9","volume":"242","author":"A Kojima","year":"2004","unstructured":"Kojima A, Ohno-Matsui K, Teramukai S, Yoshida T, Ishihara Y, Kobayashi K, Shimada N, Yasuzumi K, Futagami S, Tokoro T, Mochizuki M (2004) Factors associated with the development of chorioretinal atrophy around choroidal neovascularization in pathologic myopia. Graefes Arch Clin Exp Ophthalmol 242:114\u2013119","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR21","first-page":"721","volume":"18","author":"AE Jalkh","year":"1987","unstructured":"Jalkh AE, Weiter JJ, Trempe CL, Pruett RC, Schepens CL (1987) Choroidal neovascularization in degenerative myopia: role of laser photocoagulation. Ophthalmic Surg 18:721\u2013725","journal-title":"Ophthalmic Surg"},{"key":"1889_CR22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1177\/112067219700700401","volume":"7","author":"M Secretan","year":"1997","unstructured":"Secretan M, Kuhn D, Soubrane G, Coscas G (1997) Long-term visual outcome of choroidal neovascularization in pathologic myopia: natural history and laser treatment. Eur J Ophthalmol 7:307\u2013316","journal-title":"Eur J Ophthalmol"},{"key":"1889_CR23","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1097\/00006982-199818020-00004","volume":"18","author":"DA Johnson","year":"1998","unstructured":"Johnson DA, Yannuzzi LA, Shakin JL, Lightman DA (1998) Lacquer cracks following laser treatment of choroidal neovascularization in pathologic myopia. Retina 18:118\u2013124","journal-title":"Retina"},{"key":"1889_CR24","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/S0039-6257(00)00158-2","volume":"45","author":"U Schmidt-Erfurth","year":"2000","unstructured":"Schmidt-Erfurth U, Hasan T (2000) Mechanisms of action of photodynamic therapy with verteporfin for the treatment of age-related macular degeneration. Surv Ophthalmol 45:195\u2013214","journal-title":"Surv Ophthalmol"},{"key":"1889_CR25","first-page":"835","volume":"120","author":"U Schmidt-Erfurth","year":"2002","unstructured":"Schmidt-Erfurth U, Laqua H, Schlotzer-Schrehard U, Viestenz A, Naumann GO (2002) Histopathological changes following photodynamic therapy in human eyes. Arch Ophthalmol 120:835\u2013844","journal-title":"Arch Ophthalmol"},{"key":"1889_CR26","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0161-6420(02)01998-X","volume":"110","author":"KJ Blinder","year":"2003","unstructured":"Blinder KJ, Blumenkranz MS, Bressler NM, Bressler SB, Donato G, Lewis H, Lim JI, Menchini U, Miller JW, Mones JM, Potter MJ, Pournaras C, Reaves A, Rosenfeld P, Schachat AP, Schmidt-Erfurth U, Sickenberg M, Singerman LJ, Slakter JS, Strong HA, Virgili G, Williams GA (2003) Verteporfin therapy of subfoveal choroidal neovascularization in pathologic myopia: 2-year results of a randomized clinical trial\u2013VIP report no. 3. Ophthalmology 110:667\u2013673","journal-title":"Ophthalmology"},{"key":"1889_CR27","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1136\/bjo.2004.041624","volume":"88","author":"DS Lam","year":"2004","unstructured":"Lam DS, Chan WM, Liu DT, Fan DS, Lai WW, Chong KK (2004) Photodynamic therapy with verteporfin for subfoveal choroidal neovascularisation of pathologic myopia in Chinese eyes: a prospective series of 1 and 2\u00a0year follow up. Br J Ophthalmol 88:1315\u20131319","journal-title":"Br J Ophthalmol"},{"key":"1889_CR28","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.ajo.2004.04.055","volume":"138","author":"E Ergun","year":"2004","unstructured":"Ergun E, Heinzl H, Stur M (2004) Prognostic factors influencing visual outcome of photodynamic therapy for subfoveal choroidal neovascularization in pathologic myopia. Am J Ophthalmol 138:434\u2013438","journal-title":"Am J Ophthalmol"},{"key":"1889_CR29","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1038\/sj.eye.6701681","volume":"19","author":"DS Lam","year":"2005","unstructured":"Lam DS, Liu DT, Fan DS, Lai WW, So SF, Chan WM (2005) Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization secondary to pathologic myopia\u20141-year results of a prospective series. Eye 19:834\u2013840","journal-title":"Eye"},{"key":"1889_CR30","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.ajo.2006.11.037","volume":"143","author":"A Pece","year":"2007","unstructured":"Pece A, Vadala M, Isola V, Matranga D (2007) Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularization in pathologic myopia: a long-term follow-up study. Am J Ophthalmol 143:449\u2013454","journal-title":"Am J Ophthalmol"},{"key":"1889_CR31","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ophtha.2005.09.002","volume":"113","author":"AJ Augustin","year":"2006","unstructured":"Augustin AJ, Schmidt-Erfurth U (2006) Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration. Ophthalmology 113:14\u201322","journal-title":"Ophthalmology"},{"key":"1889_CR32","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1016\/j.ophtha.2007.02.013","volume":"114","author":"V Chaudhary","year":"2007","unstructured":"Chaudhary V, Mao A, Hooper PL, Sheidow TG (2007) Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial. Ophthalmology 114:2183\u20132189","journal-title":"Ophthalmology"},{"key":"1889_CR33","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.ajo.2006.03.003","volume":"142","author":"J Marticorena","year":"2006","unstructured":"Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M (2006) Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization. Am J Ophthalmol 142:335\u2013337","journal-title":"Am J Ophthalmol"},{"key":"1889_CR34","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1007\/s00417-007-0592-7","volume":"245","author":"J Marticorena","year":"2007","unstructured":"Marticorena J, Gomez-Ulla F, Romano MR, Luna I (2007) Repeated pseudoendophthalmitis after combined photodynamic therapy and intravitreal triamcinolone. Graefes Arch Clin Exp Ophthalmol 245:1403\u20131404","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR35","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/bjo.2006.103606","volume":"91","author":"WM Chan","year":"2007","unstructured":"Chan WM, Lai TY, Wong AL, Liu DT, Lam DS (2007) Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study. Br J Ophthalmol 91:174\u2013179","journal-title":"Br J Ophthalmol"},{"key":"1889_CR36","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s00417-006-0472-6","volume":"245","author":"MD Bennett","year":"2007","unstructured":"Bennett MD, Yee W (2007) Pegaptanib for myopic choroidal neovascularization in a young patient. Graefes Arch Clin Exp Ophthalmol 245:903\u2013905","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR37","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1038\/nature04483","volume":"438","author":"N Ferrara","year":"2005","unstructured":"Ferrara N, Kerbel RS (2005) Angiogenesis as a therapeutic target. Nature 438:967\u2013974","journal-title":"Nature"},{"key":"1889_CR38","doi-asserted-by":"crossref","first-page":"2335","DOI":"10.1056\/NEJMoa032691","volume":"350","author":"H Hurwitz","year":"2004","unstructured":"Hurwitz H, Fehrenbacher L, Novotny W, Cartwright T, Hainsworth J, Heim W, Berlin J, Baron A, Griffing S, Holmgren E, Ferrara N, Fyfe G, Rogers B, Ross R, Kabbinavar F (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350:2335\u20132342","journal-title":"N Engl J Med"},{"key":"1889_CR39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1136\/bjo.2006.099887","volume":"91","author":"H Sakaguchi","year":"2007","unstructured":"Sakaguchi H, Ikuno Y, Gomi F, Kamei M, Sawa M, Tsujikawa M, Oshima Y, Kusaka S, Tano Y (2007) Intravitreal injection of bevacizumab for choroidal neovascularisation associated with pathological myopia. Br J Ophthalmol 91:161\u2013165","journal-title":"Br J Ophthalmol"},{"key":"1889_CR40","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/IAE.0b013e3181b1bb1a","volume":"29","author":"SY Cohen","year":"2009","unstructured":"Cohen SY (2009) Anti-VEGF drugs as the 2009 first-line therapy for choroidal neovascularization in pathologic myopia. Retina 29:1062\u20131066","journal-title":"Retina"},{"key":"1889_CR41","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ajo.2008.07.022","volume":"147","author":"M Gharbiya","year":"2009","unstructured":"Gharbiya M, Allievi F, Mazzeo L, Gabrieli CB (2009) Intravitreal bevacizumab treatment for choroidal neovascularization in pathologic myopia: 12-month results. Am J Ophthalmol 147:84\u201393","journal-title":"Am J Ophthalmol"},{"key":"1889_CR42","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.ajo.2008.07.017","volume":"147","author":"Y Ikuno","year":"2009","unstructured":"Ikuno Y, Sayanagi K, Soga K, Sawa M, Tsujikawa M, Gomi F, Tano Y (2009) Intravitreal bevacizumab for choroidal neovascularization attributable to pathological myopia: one-year results. Am J Ophthalmol 147:94\u2013100","journal-title":"Am J Ophthalmol"},{"key":"1889_CR43","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.1038\/eye.2008.404","volume":"23","author":"PC Wu","year":"2009","unstructured":"Wu PC, Chen YJ (2009) Intravitreal injection of bevacizumab for myopic choroidal neovascularization: 1-year follow-up. Eye 23:2042\u20132045","journal-title":"Eye"},{"key":"1889_CR44","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1097\/IAE.0b013e3181e22659","volume":"30","author":"JM Ruiz-Moreno","year":"2010","unstructured":"Ruiz-Moreno JM, Montero JA, Arias L, Araiz J, Gomez-Ulla F, Silva R, Pinero DP (2010) Twelve-month outcome after one intravitreal injection of bevacizumab to treat myopic choroidal neovascularization. Retina 30:1609\u20131615","journal-title":"Retina"},{"key":"1889_CR45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1136\/bjo.2008.145797","volume":"93","author":"WM Chan","year":"2009","unstructured":"Chan WM, Lai TY, Liu DT, Lam DS (2009) Intravitreal bevacizumab (Avastin) for myopic choroidal neovascularisation: 1-year results of a prospective pilot study. Br J Ophthalmol 93:150\u2013154","journal-title":"Br J Ophthalmol"},{"key":"1889_CR46","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1136\/bjo.2008.145391","volume":"93","author":"JM Ruiz-Moreno","year":"2009","unstructured":"Ruiz-Moreno JM, Montero JA, Gomez-Ulla F, Ares S (2009) Intravitreal bevacizumab to treat subfoveal choroidal neovascularisation in highly myopic eyes: 1-year outcome. Br J Ophthalmol 93:448\u2013451","journal-title":"Br J Ophthalmol"},{"key":"1889_CR47","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.ajo.2009.03.026","volume":"148","author":"K Hayashi","year":"2009","unstructured":"Hayashi K, Ohno-Matsui K, Teramukai S, Shimada N, Moriyama M, Hayashi W, Yoshida T, Tokoro T, Mochizuki M (2009) Comparison of visual outcome and regression pattern of myopic choroidal neovascularization after intravitreal bevacizumab or after photodynamic therapy. Am J Ophthalmol 148:396\u2013408","journal-title":"Am J Ophthalmol"},{"key":"1889_CR48","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.ajo.2009.08.008","volume":"149","author":"Y Ikuno","year":"2010","unstructured":"Ikuno Y, Nagai Y, Matsuda S, Arisawa A, Sho K, Oshita T, Takahashi K, Uchihori Y, Gomi F (2010) Two-year visual results for older Asian women treated with photodynamic therapy or bevacizumab for myopic choroidal neovascularization. Am J Ophthalmol 149:140\u2013146","journal-title":"Am J Ophthalmol"},{"key":"1889_CR49","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1136\/bjo.2009.166025","volume":"94","author":"T Baba","year":"2010","unstructured":"Baba T, Kubota-Taniai M, Kitahashi M, Okada K, Mitamura Y, Yamamoto S (2010) Two-year comparison of photodynamic therapy and intravitreal bevacizumab for treatment of myopic choroidal neovascularisation. Br J Ophthalmol 94:864\u2013870","journal-title":"Br J Ophthalmol"},{"key":"1889_CR50","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1097\/IAE.0b013e3181bd2fe4","volume":"30","author":"JU Yoon","year":"2010","unstructured":"Yoon JU, Byun YJ, Koh HJ (2010) Intravitreal anti-VEGF versus photodynamic therapy with verteporfin for treatment of myopic choroidal neovascularization. Retina 30:418\u2013424","journal-title":"Retina"},{"key":"1889_CR51","first-page":"3397","volume":"48","author":"F Ziemssen","year":"2007","unstructured":"Ziemssen F, Inhoffen W, Voelcker M, Grisanti S, Szurman P, Bartz-Schmidt KU, Gelisken F; Tuebingen Bevacizumab Study Group (2007) Intravitreous bevacizumab monotherapy vs combined therapy (bevacizumab\u2009+\u2009PDT) of choroidal neovascularization in pathological myopia: outcome and re-treatment. Invest Ophthalmol Vis Sci 48:3397","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1889_CR52","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1167\/iovs.08-2517","volume":"50","author":"C Battista","year":"2009","unstructured":"Battista C, Nardoni S, Romani A (2009) Combined intravitreal avastin injection and photodynamic therapy for the treatment of macular choroidal neovascularization in pathological myopia. Invest Ophthalmol Vis Sci 50:2266","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1889_CR53","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ophtha.2010.04.016","volume":"118","author":"JS Heier","year":"2011","unstructured":"Heier JS, Brown D, Ciulla T, Abraham P, Bankert JM, Chong S, Daniel PE Jr, Kim IK (2011) Ranibizumab for choroidal neovascularization secondary to causes other than age-related macular degeneration: a phase I clinical trial. Ophthalmology 118:111\u2013118","journal-title":"Ophthalmology"},{"key":"1889_CR54","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/s00417-008-0995-0","volume":"247","author":"L Konstantinidis","year":"2009","unstructured":"Konstantinidis L, Mantel I, Pournaras JA, Zografos L, Ambresin A (2009) Intravitreal ranibizumab (Lucentis) for the treatment of myopic choroidal neovascularization. Graefes Arch Clin Exp Ophthalmol 247:311\u2013318","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR55","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1097\/IAE.0b013e31817eda41","volume":"28","author":"RM Silva","year":"2008","unstructured":"Silva RM, Ruiz-Moreno JM, Nascimento J, Carneiro A, Rosa P, Barbosaa A, Carvalheira F, Abreu JR, Cunha-Vaz JG (2008) Short-term efficacy and safety of intravitreal ranibizumab for myopic choroidal neovascularization. Retina 28:1117\u20131123","journal-title":"Retina"},{"key":"1889_CR56","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1038\/eye.2009.88","volume":"23","author":"JM Mones","year":"2009","unstructured":"Mones JM, Amselem L, Serrano A, Garcia M, Hijano M (2009) Intravitreal ranibizumab for choroidal neovascularization secondary to pathologic myopia: 12-month results. Eye (Lond) 23:1275\u20131280","journal-title":"Eye (Lond)"},{"key":"1889_CR57","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1097\/IAE.0b013e3181c9691e","volume":"30","author":"RM Silva","year":"2010","unstructured":"Silva RM, Ruiz-Moreno JM, Rosa P, Carneiro A, Nascimento J, Rito LF, Cachulo ML, Carvalheira F, Murta JN (2010) Intravitreal ranibizumab for myopic choroidal neovascularization: 12-month results. Retina 30:407\u2013412","journal-title":"Retina"},{"key":"1889_CR58","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/IAE.0b013e3181bcef24","volume":"30","author":"F Lalloum","year":"2010","unstructured":"Lalloum F, Souied EH, Bastuji-Garin S, Puche N, Querques G, Glacet-Bernard A, Coscas G, Soubrane G, Leveziel N (2010) Intravitreal ranibizumab for choroidal neovascularization complicating pathologic myopia. Retina 30:399\u2013406","journal-title":"Retina"},{"key":"1889_CR59","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.jfo.2010.03.006","volume":"33","author":"PL Cornut","year":"2010","unstructured":"Cornut PL, Poli M, Feldman A, El CH, Swalduz B, Burillon C, Denis P (2010) Intravitreal ranibizumab for choroidal neovascularization secondary to pathological myopia: 12-month results. J Fr Ophtalmol 33:327\u2013333","journal-title":"J Fr Ophtalmol"},{"key":"1889_CR60","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ajo.2009.10.010","volume":"149","author":"M Gharbiya","year":"2010","unstructured":"Gharbiya M, Giustolisi R, Allievi F, Fantozzi N, Mazzeo L, Scavella V, Gabrieli CB (2010) Choroidal neovascularization in pathologic myopia: intravitreal ranibizumab versus bevacizumab\u2013a randomized controlled trial. Am J Ophthalmol 149:458\u2013464","journal-title":"Am J Ophthalmol"},{"key":"1889_CR61","first-page":"1457","volume":"48","author":"TP Wong","year":"2007","unstructured":"Wong TP, Brown DM, Benz MS (2007) Phase II clinical trial of intravenous combretastatin a4 phosphate in patients with subfoveal choroidal neovascular membranes (CNV) in pathologic myopia. Invest Ophthalmol Vis Sci 48:1457","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1889_CR62","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1167\/iovs.08-2706","volume":"50","author":"JS Heier","year":"2009","unstructured":"Heier JS, CLEAR-IT (2009) CLEAR-IT 2: phase 2, randomized, controlled dose-and interval-ranging study of intravitreal VEGF Trap Eye in patients with neovascular age-related macular degeneration: predictive factors for visual acuity outcome at one year. Invest Ophthalmol Vis Sci 50:1255","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"1889_CR63","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/S0002-9394(02)02257-2","volume":"135","author":"RA Costa","year":"2003","unstructured":"Costa RA, Calucci D, Teixeira LF, Cardillo JA, Bonomo PP (2003) Selective occlusion of subfoveal choroidal neovascularization in pathologic myopia using a new technique of ingrowth site treatment. Am J Ophthalmol 135:857\u2013866","journal-title":"Am J Ophthalmol"},{"key":"1889_CR64","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.ajo.2010.02.006","volume":"150","author":"PK Kaiser","year":"2010","unstructured":"Kaiser PK, Symons RC, Shah SM, Quinlan EJ, Tabandeh H, Do DV, Reisen G, Lockridge JA, Short B, Guerciolini R, Nguyen QD (2010) RNAi-based treatment for neovascular age-related macular degeneration by Sirna-027. Am J Ophthalmol 150:33\u201339","journal-title":"Am J Ophthalmol"},{"issue":"4","key":"1889_CR65","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/j.ophtha.2010.08.008","volume":"118","author":"M Zhang","year":"2010","unstructured":"Zhang M, Zhang J, Yan M, Luo D, Zhu W, Kaiser PK, Yu DC (2010) A phase 1 study of KH902, a vascular endothelial growth factor receptor decoy, for exudative age-related macular degeneration. Ophthalmology 118(4):672\u2013678","journal-title":"Ophthalmology"},{"key":"1889_CR66","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1159\/000228926","volume":"223","author":"Z Ni","year":"2009","unstructured":"Ni Z, Hui P (2009) Emerging pharmacologic therapies for wet age-related macular degeneration. Ophthalmologica 223:401\u2013410","journal-title":"Ophthalmologica"},{"key":"1889_CR67","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1001\/archopht.122.11.1616","volume":"122","author":"BS Hawkins","year":"2004","unstructured":"Hawkins BS, Miskala PH, Bass EB, Bressler NM, Childs AL, Mangione CM, Marsh MJ (2004) Surgical removal vs observation for subfoveal choroidal neovascularization, either associated with the ocular histoplasmosis syndrome or idiopathic: II. Quality-of-life findings from a randomized clinical trial: SST Group H Trial: SST Report No. 10. Arch Ophthalmol 122:1616\u20131628","journal-title":"Arch Ophthalmol"},{"key":"1889_CR68","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1001\/archopht.118.3.344","volume":"118","author":"A Uemura","year":"2000","unstructured":"Uemura A, Thomas MA (2000) Subretinal surgery for choroidal neovascularization in patients with high myopia. Arch Ophthalmol 118:344\u2013350","journal-title":"Arch Ophthalmol"},{"key":"1889_CR69","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1136\/bjo.85.9.1041","volume":"85","author":"JM Ruiz-Moreno","year":"2001","unstructured":"Ruiz-Moreno JM, De la Vega C (2001) Surgical removal of subfoveal choroidal neovascularisation in highly myopic patients. Br J Ophthalmol 85:1041\u20131043","journal-title":"Br J Ophthalmol"},{"key":"1889_CR70","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S0002-9394(02)01335-1","volume":"133","author":"N Hamelin","year":"2002","unstructured":"Hamelin N, Glacet-Bernard A, Brindeau C, Mimoun G, Coscas G, Soubrane G (2002) Surgical treatment of subfoveal neovascularization in myopia: macular translocation vs surgical removal. Am J Ophthalmol 133:530\u2013536","journal-title":"Am J Ophthalmol"},{"key":"1889_CR71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/BF00921957","volume":"231","author":"R Machemer","year":"1993","unstructured":"Machemer R, Steinhorst UH (1993) Retinal separation, retinotomy, and macular relocation: II. A surgical approach for age-related macular degeneration? Graefes Arch Clin Exp Ophthalmol 231:635\u2013641","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"1889_CR72","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.ajo.2004.05.029","volume":"138","author":"M Kamei","year":"2004","unstructured":"Kamei M, Tano Y, Yasuhara T, Ohji M, Lewis H (2004) Macular translocation with chorioscleral outfolding: 2-year results. Am J Ophthalmol 138:574\u2013581","journal-title":"Am J Ophthalmol"},{"key":"1889_CR73","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0002-9394(99)00186-5","volume":"128","author":"M Takano","year":"1999","unstructured":"Takano M, Kishi S (1999) Foveal retinoschisis and retinal detachment in severely myopic eyes with posterior staphyloma. Am J Ophthalmol 128:472\u2013476","journal-title":"Am J Ophthalmol"},{"key":"1889_CR74","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S0002-9394(02)01394-6","volume":"133","author":"N Benhamou","year":"2002","unstructured":"Benhamou N, Massin P, Haouchine B, Erginay A, Gaudric A (2002) Macular retinoschisis in highly myopic eyes. Am J Ophthalmol 133:794\u2013800","journal-title":"Am J Ophthalmol"},{"key":"1889_CR75","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.ajo.2006.10.053","volume":"143","author":"D Gaucher","year":"2007","unstructured":"Gaucher D, Haouchine B, Tadayoni R, Massin P, Erginay A, Benhamou N, Gaudric A (2007) Long-term follow-up of high myopic foveoschisis: natural course and surgical outcome. Am J Ophthalmol 143:455\u2013462","journal-title":"Am J Ophthalmol"},{"key":"1889_CR76","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1001\/archopht.124.8.1197","volume":"124","author":"IU Scott","year":"2006","unstructured":"Scott IU, Moshfeghi AA, Flynn HW Jr (2006) Surgical management of macular retinoschisis associated with high myopia. Arch Ophthalmol 124:1197\u20131199","journal-title":"Arch Ophthalmol"},{"key":"1889_CR77","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1016\/S0161-6420(03)00714-0","volume":"110","author":"H Kobayashi","year":"2003","unstructured":"Kobayashi H, Kishi S (2003) Vitreous surgery for highly myopic eyes with foveal detachment and retinoschisis. Ophthalmology 110:1702\u20131707","journal-title":"Ophthalmology"},{"key":"1889_CR78","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajo.2006.04.046","volume":"142","author":"T Baba","year":"2006","unstructured":"Baba T, Tanaka S, Maesawa A, Teramatsu T, Noda Y, Yamamoto S (2006) Scleral buckling with macular plombe for eyes with myopic macular retinoschisis and retinal detachment without macular hole. Am J Ophthalmol 142:483\u2013487","journal-title":"Am J Ophthalmol"},{"key":"1889_CR79","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1038\/eye.2008.433","volume":"23","author":"B Ward","year":"2009","unstructured":"Ward B, Tarutta EP, Mayer MJ (2009) The efficacy and safety of posterior pole buckles in the control of progressive high myopia. Eye 23:2169\u20132174","journal-title":"Eye"},{"key":"1889_CR80","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1442-9071.2009.02111.x","volume":"37","author":"Z Zhu","year":"2009","unstructured":"Zhu Z, Ji X, Zhang J, Ke G (2009) Posterior scleral reinforcement in the treatment of macular retinoschisis in highly myopic patients. Clin Experiment Ophthalmol 37:660\u2013663","journal-title":"Clin Experiment Ophthalmol"},{"key":"1889_CR81","doi-asserted-by":"crossref","first-page":"122","DOI":"10.3109\/08820530009040003","volume":"15","author":"TJ Wolfensberger","year":"2000","unstructured":"Wolfensberger TJ, Gonvers M (2000) Surgical treatment of retinal detachment owing to macular hole. Semin Ophthalmol 15:122\u2013127","journal-title":"Semin Ophthalmol"},{"key":"1889_CR82","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00006982-199111030-00002","volume":"11","author":"H Morita","year":"1991","unstructured":"Morita H, Ideta H, Ito K, Yonemoto J, Sasaki K, Tanaka S (1991) Causative factors of retinal detachment in macular holes. Retina 11:281\u2013284","journal-title":"Retina"},{"key":"1889_CR83","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1016\/S0002-9394(99)00240-8","volume":"128","author":"J Akiba","year":"1999","unstructured":"Akiba J, Konno S, Yoshida A (1999) Retinal detachment associated with a macular hole in severely myopic eyes. Am J Ophthalmol 128:654\u2013655","journal-title":"Am J Ophthalmol"},{"key":"1889_CR84","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0002-9394(03)00269-1","volume":"136","author":"Y Ikuno","year":"2003","unstructured":"Ikuno Y, Sayanagi K, Oshima T, Gomi F, Kusaka S, Kamei M, Ohji M, Fujikado T, Tano Y (2003) Optical coherence tomographic findings of macular holes and retinal detachment after vitrectomy in highly myopic eyes. Am J Ophthalmol 136:477\u2013481","journal-title":"Am J Ophthalmol"},{"key":"1889_CR85","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/S0002-9394(03)00186-7","volume":"136","author":"M Ichibe","year":"2003","unstructured":"Ichibe M, Yoshizawa T, Murakami K, Ohta M, Oya Y, Yamamoto S, Funaki S, Funaki H, Ozawa Y, Baba E, Abe H (2003) Surgical management of retinal detachment associated with myopic macular hole: anatomic and functional status of the macula. Am J Ophthalmol 136:277\u2013284","journal-title":"Am J Ophthalmol"},{"key":"1889_CR86","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1016\/j.ajo.2005.11.044","volume":"141","author":"Y Ikuno","year":"2006","unstructured":"Ikuno Y, Tano Y (2006) Vitrectomy for macular holes associated with myopic foveoschisis. Am J Ophthalmol 141:774\u2013776","journal-title":"Am J Ophthalmol"},{"key":"1889_CR87","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0002-9394(00)00728-5","volume":"131","author":"K Kadonosono","year":"2001","unstructured":"Kadonosono K, Yazama F, Itoh N, Uchio E, Nakamura S, Akura J, Sawada H, Ohno S (2001) Treatment of retinal detachment resulting from myopic macular hole with internal limiting membrane removal. Am J Ophthalmol 131:203\u2013207","journal-title":"Am J Ophthalmol"},{"key":"1889_CR88","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1097\/00006982-199701000-00001","volume":"17","author":"C Seike","year":"1997","unstructured":"Seike C, Kusaka S, Sakagami K, Ohashi Y (1997) Reopening of macular holes in highly myopic eyes with retinal detachments. Retina 17:2\u20136","journal-title":"Retina"},{"key":"1889_CR89","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00006982-200102000-00003","volume":"21","author":"H Tabandeh","year":"2001","unstructured":"Tabandeh H, Smiddy WE, Mello M, Alexandrakis G, Flynn HW Jr, Gregor Z, Schiffman J (2001) Surgery for idiopathic macular holes associated with extensive subretinal fluid. Retina 21:15\u201319","journal-title":"Retina"},{"key":"1889_CR90","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/00006982-200601000-00005","volume":"26","author":"YP Chen","year":"2006","unstructured":"Chen YP, Chen TL, Yang KR, Lee WH, Kuo YH, Chao AN, Wu WC, Chen KJ, Lai CC (2006) Treatment of retinal detachment resulting from posterior staphyloma-associated macular hole in highly myopic eyes. Retina 26:25\u201331","journal-title":"Retina"},{"key":"1889_CR91","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1046\/j.1442-9071.2002.00530.x","volume":"30","author":"L Lu","year":"2002","unstructured":"Lu L, Li Y, Cai S, Yang J (2002) Vitreous surgery in highly myopic retinal detachment resulting from a macular hole. Clin Experiment Ophthalmol 30:261\u2013265","journal-title":"Clin Experiment Ophthalmol"},{"key":"1889_CR92","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1136\/bjo.2006.111526","volume":"91","author":"BT Cheung","year":"2007","unstructured":"Cheung BT, Lai TY, Yuen CY, Lai WW, Tsang CW, Lam DS (2007) Results of high-density silicone oil as a tamponade agent in macular hole retinal detachment in patients with high myopia. Br J Ophthalmol 91:719\u2013721","journal-title":"Br J Ophthalmol"},{"key":"1889_CR93","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.ajo.2010.07.023","volume":"151","author":"A Nishimura","year":"2011","unstructured":"Nishimura A, Kimura M, Saito Y, Sugiyama K (2011) Efficacy of primary silicone oil tamponade for the treatment of retinal detachment caused by macular hole in high myopia. Am J Ophthalmol 151:148\u2013155","journal-title":"Am J Ophthalmol"},{"key":"1889_CR94","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1097\/01.iae.0000256660.48993.9e","volume":"27","author":"F Ando","year":"2007","unstructured":"Ando F, Ohba N, Touura K, Hirose H (2007) Anatomical and visual outcomes after episcleral macular buckling compared with those after pars plana vitrectomy for retinal detachment caused by macular hole in highly myopic eyes. Retina 27:37\u201344","journal-title":"Retina"},{"key":"1889_CR95","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/00006982-200005000-00003","volume":"20","author":"M Sasoh","year":"2000","unstructured":"Sasoh M, Yoshida S, Ito Y, Matsui K, Osawa S, Uji Y (2000) Macular buckling for retinal detachment due to macular hole in highly myopic eyes with posterior staphyloma. Retina 20:445\u2013449","journal-title":"Retina"},{"key":"1889_CR96","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1016\/S0161-6420(01)00861-2","volume":"108","author":"G Ripandelli","year":"2001","unstructured":"Ripandelli G, Coppe AM, Fedeli R, Parisi V, D\u2019Amico DJ, Stirpe M (2001) Evaluation of primary surgical procedures for retinal detachment with macular hole in highly myopic eyes: a comparison [corrected] of vitrectomy versus posterior episcleral buckling surgery. Ophthalmology 108:2258\u20132264","journal-title":"Ophthalmology"},{"key":"1889_CR97","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/IAE.0b013e3181fc7e73","volume":"31","author":"F Devin","year":"2011","unstructured":"Devin F, Tsui I, Morin B, Duprat JP, Hubschman JP (2011) T-shaped scleral buckle for macular detachments in high myopes. Retina 31:177\u2013180","journal-title":"Retina"}],"container-title":["Graefe's Archive for Clinical and Experimental Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1889-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00417-011-1889-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00417-011-1889-0","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,20]],"date-time":"2019-06-20T19:48:31Z","timestamp":1561060111000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00417-011-1889-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,12,13]]},"references-count":97,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,1]]}},"alternative-id":["1889"],"URL":"https:\/\/doi.org\/10.1007\/s00417-011-1889-0","relation":{},"ISSN":["0721-832X","1435-702X"],"issn-type":[{"value":"0721-832X","type":"print"},{"value":"1435-702X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,12,13]]}}}